Research

Hormonal

Metformin augmentation for non-responders to initial behavioral interventions provides a potential rescue effect but is associated with gastrointestinal side effects that challenge adherence.

If behavioral changes alone don't improve your insulin sensitivity, adding metformin might help, but be prepared for potential stomach issues. Starting with a low dose and using extended-release versions can help manage side effects.

ModerateQualifiesMEDIUM confidence
Among non-responders, WLC and metformin provided a potential rescue effect, but overall insulin sensitivity remained lower than at of responders. Metformin adherence posed challenges due to frequent gastrointestinal side effects and difficulties tracking usage.
Aseel El Zein et al. · Pilot and Feasibility Studies · 2025

Why this rating

Pilot study, qualitative adherence data, no statistical power for efficacy.

Source

A pilot sequential multiple assignment randomized trial for developing a biobehavioral adaptive intervention to improve insulin sensitivity in patients with stage 1 obesity

Aseel El Zein et al. · Pilot and Feasibility Studies · 2025

DOI 10.1186/s40814-025-01618-4

rct · n=40Cited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →